These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8587600)

  • 1. Pulling the trigger on psoriasis.
    Boehncke WH; Dressel D; Zollner TM; Kaufmann R
    Nature; 1996 Feb; 379(6568):777. PubMed ID: 8587600
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis.
    Boehncke WH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):231-2. PubMed ID: 11924833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
    Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
    J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
    Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
    J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigens in skin diseases.
    Saloga J; Knop J
    Eur J Dermatol; 1999; 9(7):586-90; quiz 591. PubMed ID: 10523743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.
    Boehncke WH; Ochsendorf FR; Noll S; Urban M; Popp A; Waldherr D; Haunschild J; Litzenburger T
    Br J Dermatol; 2005 Oct; 153(4):758-66. PubMed ID: 16181457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superantigens, autoantigens, and pathogenic T cells in psoriasis.
    Nickoloff BJ; Wrone-Smith T
    J Invest Dermatol; 1998 Apr; 110(4):459-60. PubMed ID: 9540994
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal models of psoriasis.
    Boehncke WH; Schön MP
    Clin Dermatol; 2007; 25(6):596-605. PubMed ID: 18021898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique superantigen activity of staphylococcal exfoliative toxins.
    Monday SR; Vath GM; Ferens WA; Deobald C; Rago JV; Gahr PJ; Monie DD; Iandolo JJ; Chapes SK; Davis WC; Ohlendorf DH; Schlievert PM; Bohach GA
    J Immunol; 1999 Apr; 162(8):4550-9. PubMed ID: 10201994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of tonsillar lymphocytes in associated with HSP60/65 in Pustulosis palmaris et plantaris.
    Hayashi M; Fujihara K; Beder LB; Yamamoto Y; Hotomi M; Yamanaka N
    Auris Nasus Larynx; 2009 Oct; 36(5):578-85. PubMed ID: 19268507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between activity and a circulating lymphocyte pattern in plasma of patients with psoriasis preceded by an infection.
    Lecewicz-Toruń B; Pietrzak A; Roliński J
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():269-76. PubMed ID: 11205775
    [No Abstract]   [Full Text] [Related]  

  • 12. Superantigens: a brief review with special emphasis on dermatologic diseases.
    Solanki LS; Srivastava N; Singh S
    Dermatol Online J; 2008 Feb; 14(2):3. PubMed ID: 18700106
    [No Abstract]   [Full Text] [Related]  

  • 13. Psoriasis: more than skin deep.
    Pittelkow MR
    Nat Med; 2005 Jan; 11(1):17-8. PubMed ID: 15635435
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical analysis of staphylococcal superantigen hyper-reactive patients with psoriasis vulgaris.
    Yamamoto T; Katayama I; Nishioka K
    Eur J Dermatol; 1998; 8(5):325-9. PubMed ID: 9683864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin?
    Valdimarsson H; Sigmundsdóttir H; Jónsdóttir I
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():21-4. PubMed ID: 9020931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of psoriasis: a critical appraisal.
    Schön MP
    Exp Dermatol; 2008 Aug; 17(8):703-12. PubMed ID: 18557923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial superantigen staphylococcal enterotoxin B induces interstitial pneumonia in SCID mice reconstituted with peripheral blood mononuclear cells from collagen vascular disease patients.
    Fujiki M; Shinbori T; Suga M; Miyakawa H; Mizobe T; Ando M
    Clin Immunol; 2000 Jul; 96(1):38-43. PubMed ID: 10873426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.
    Sano S; Chan KS; Carbajal S; Clifford J; Peavey M; Kiguchi K; Itami S; Nickoloff BJ; DiGiovanni J
    Nat Med; 2005 Jan; 11(1):43-9. PubMed ID: 15592573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological reactivity in psoriasis. Autografts of and on skin undamaged by psoriasis].
    Leigheb G; Visetti M; Albertazzi F
    Minerva Dermatol; 1966 Nov; 41(11):397-400. PubMed ID: 4872502
    [No Abstract]   [Full Text] [Related]  

  • 20. 7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immunodeficient mouse transplant model.
    Bhagavathula N; Nerusu KC; Hanosh A; Aslam MN; Sundberg TB; Opipari AW; Johnson K; Kang S; Glick GD; Varani J
    J Pharmacol Exp Ther; 2008 Mar; 324(3):938-47. PubMed ID: 18055879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.